[Percentage of asthmatic patients with acute bronchitis and Chlamydia pneumoniae seropositivity].
Orfila
J
J
Godard
P
P
D000208:Acute Disease; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000907:Antibodies, Bacterial / Q000032:analysis*; D001249:Asthma / Q000150:complications / Q000209:etiology*; D001991:Bronchitis / Q000209:etiology*; D023521:Chlamydophila Infections / Q000150:complications* / Q000175:diagnosis / Q000276:immunology; D016993:Chlamydophila pneumoniae / Q000276:immunology*; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D015575:Roxithromycin / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors
D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D015575:Roxithromycin